News
Moderna Inc. is cutting about 10% of its workforce, part of an effort by the struggling biotech company to reduce spending as ...
The layoffs come as Moderna’s cash position has raised worries on Wall Street that the company may need to raise new capital.
Moderna said on Thursday it would trim roughly 10% of its global workforce and have fewer than 5,000 employees by the end of ...
Moderna will cut around 10% of its global workforce by year-end to reduce costs, as Covid vaccine sales decline. It aims for ...
In a memo, CEO Stéphane Bancel said the job cuts are needed to align the struggling vaccine maker’s cost structure with the ...
Massachusetts-based Moderna, one of the companies at the forefront of developing a vaccine during the COVID pandemic, ...
The Moderna layoffs are aimed at cutting costs amid declining vaccine sales and a shifting regulatory landscape.
Moderna Inc. (NASDAQ: MRNA) has announced plans to reduce its global workforce by approximately 10% by the end of the year ...
Despite efforts to spare employees by scaling back R&D and reducing operating costs by roughly $1.5 billion over the next two ...
Moderna plans to reduce its global workforce by approximately 10% by year-end due to declining Covid-19 vaccine sales. The company aims for eight new product approvals by 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results